Cargando…

Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study

BACKGROUND: Growth differentiation factor‐15 (GDF‐15) has emerged as a novel biomarker to predict all‐cause death in community‐dwelling individuals and patients with cardiovascular disease. We evaluated the prognostic value of GDF‐15 in outpatients with cardiovascular risk factors. METHODS AND RESUL...

Descripción completa

Detalles Bibliográficos
Autores principales: Negishi, Keita, Hoshide, Satoshi, Shimpo, Masahisa, Kanegae, Hiroshi, Kario, Kazuomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075247/
https://www.ncbi.nlm.nih.gov/pubmed/34889104
http://dx.doi.org/10.1161/JAHA.121.022601
_version_ 1784701639319355392
author Negishi, Keita
Hoshide, Satoshi
Shimpo, Masahisa
Kanegae, Hiroshi
Kario, Kazuomi
author_facet Negishi, Keita
Hoshide, Satoshi
Shimpo, Masahisa
Kanegae, Hiroshi
Kario, Kazuomi
author_sort Negishi, Keita
collection PubMed
description BACKGROUND: Growth differentiation factor‐15 (GDF‐15) has emerged as a novel biomarker to predict all‐cause death in community‐dwelling individuals and patients with cardiovascular disease. We evaluated the prognostic value of GDF‐15 in outpatients with cardiovascular risk factors. METHODS AND RESULTS: GDF‐15 levels were measured in 3562 outpatients with cardiovascular risk factors in the J‐HOP (Japan Morning Surge‐Home Blood Pressure) study, a nationwide prospective study. Participants were stratified according to tertiles of GDF‐15 and followed up for all‐cause death and cardiovascular disease. During a mean follow‐up period of 6.6 years, there were 155 all‐cause deaths, 81 stroke events including cerebral infarction and intracranial hemorrhage, and 141 cardiac events including cardiac artery disease and heart failure. Patients with higher GDF‐15 levels were associated with risks of all‐cause death and stroke events (except for cardiac events) after adjustment for traditional risk factors and other prognostic biomarkers (NT‐proBNP [N‐terminal pro‐B‐type natriuretic peptide], high‐sensitivity troponin T; all‐cause death, hazard ratio, 2.38; 95% CI, 1.26–4.48; P=0.007; stroke events, hazard ratio, 2.93; 95% CI, 1.31–6.56, P=0.009; compared with the lowest tertile). Furthermore, incorporating GDF‐15 to the predictive models for all‐cause death improved discrimination and reclassification significantly. For stroke events, GDF‐15 showed similar diagnostic accuracy to NT‐proBNP and high‐sensitivity troponin T. CONCLUSIONS: In Japanese outpatients with cardiovascular risk factors, GDF‐15 improves risk stratification for all‐cause death when compared with NT‐proBNP and high‐sensitivity troponin T. GDF‐15 was associated with increased risks of stroke events beyond conventional risk factors and other prognostic markers; however, the predictive ability for stroke events was equivalent to NT‐proBNP and high‐sensitivity troponin T. REGISTRATION: URL: http://www.umin.ac.jp/ctr.; Unique identifier: UMIN000000894.
format Online
Article
Text
id pubmed-9075247
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90752472022-05-10 Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study Negishi, Keita Hoshide, Satoshi Shimpo, Masahisa Kanegae, Hiroshi Kario, Kazuomi J Am Heart Assoc Original Research BACKGROUND: Growth differentiation factor‐15 (GDF‐15) has emerged as a novel biomarker to predict all‐cause death in community‐dwelling individuals and patients with cardiovascular disease. We evaluated the prognostic value of GDF‐15 in outpatients with cardiovascular risk factors. METHODS AND RESULTS: GDF‐15 levels were measured in 3562 outpatients with cardiovascular risk factors in the J‐HOP (Japan Morning Surge‐Home Blood Pressure) study, a nationwide prospective study. Participants were stratified according to tertiles of GDF‐15 and followed up for all‐cause death and cardiovascular disease. During a mean follow‐up period of 6.6 years, there were 155 all‐cause deaths, 81 stroke events including cerebral infarction and intracranial hemorrhage, and 141 cardiac events including cardiac artery disease and heart failure. Patients with higher GDF‐15 levels were associated with risks of all‐cause death and stroke events (except for cardiac events) after adjustment for traditional risk factors and other prognostic biomarkers (NT‐proBNP [N‐terminal pro‐B‐type natriuretic peptide], high‐sensitivity troponin T; all‐cause death, hazard ratio, 2.38; 95% CI, 1.26–4.48; P=0.007; stroke events, hazard ratio, 2.93; 95% CI, 1.31–6.56, P=0.009; compared with the lowest tertile). Furthermore, incorporating GDF‐15 to the predictive models for all‐cause death improved discrimination and reclassification significantly. For stroke events, GDF‐15 showed similar diagnostic accuracy to NT‐proBNP and high‐sensitivity troponin T. CONCLUSIONS: In Japanese outpatients with cardiovascular risk factors, GDF‐15 improves risk stratification for all‐cause death when compared with NT‐proBNP and high‐sensitivity troponin T. GDF‐15 was associated with increased risks of stroke events beyond conventional risk factors and other prognostic markers; however, the predictive ability for stroke events was equivalent to NT‐proBNP and high‐sensitivity troponin T. REGISTRATION: URL: http://www.umin.ac.jp/ctr.; Unique identifier: UMIN000000894. John Wiley and Sons Inc. 2021-12-10 /pmc/articles/PMC9075247/ /pubmed/34889104 http://dx.doi.org/10.1161/JAHA.121.022601 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Negishi, Keita
Hoshide, Satoshi
Shimpo, Masahisa
Kanegae, Hiroshi
Kario, Kazuomi
Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
title Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
title_full Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
title_fullStr Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
title_full_unstemmed Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
title_short Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
title_sort growth differentiation factor‐15 predicts death and stroke event in outpatients with cardiovascular risk factors: the j‐hop study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075247/
https://www.ncbi.nlm.nih.gov/pubmed/34889104
http://dx.doi.org/10.1161/JAHA.121.022601
work_keys_str_mv AT negishikeita growthdifferentiationfactor15predictsdeathandstrokeeventinoutpatientswithcardiovascularriskfactorsthejhopstudy
AT hoshidesatoshi growthdifferentiationfactor15predictsdeathandstrokeeventinoutpatientswithcardiovascularriskfactorsthejhopstudy
AT shimpomasahisa growthdifferentiationfactor15predictsdeathandstrokeeventinoutpatientswithcardiovascularriskfactorsthejhopstudy
AT kanegaehiroshi growthdifferentiationfactor15predictsdeathandstrokeeventinoutpatientswithcardiovascularriskfactorsthejhopstudy
AT kariokazuomi growthdifferentiationfactor15predictsdeathandstrokeeventinoutpatientswithcardiovascularriskfactorsthejhopstudy